|
Oct 22, 2020
|
Dynavax to Report Third Quarter 2020 Financial Results and Host Conference Call on November 5, 2020
|
|
|
Oct 13, 2020
|
Medigen's COVID-19 Vaccine Combined with Dynavax's CpG 1018 Adjuvant Receives Taiwan Government Subsidy with First Participant Dosed in Early October
|
|
|
Sep 25, 2020
|
Clover Biopharmaceuticals Announces Positive Preclinical Data and Updates on Phase 1 Study for its Adjuvanted S-Trimer COVID-19 Vaccine Candidate
|
|
|
Sep 24, 2020
|
Dynavax Announces Appointment of New Board Member and Planned Retirement of Chief Financial Officer
|
|
|
Sep 14, 2020
|
Valneva and Dynavax Announce Commercial Supply Agreement for Inactivated, Adjuvanted COVID-19 Vaccine
|
|
|
Aug 31, 2020
|
Dynavax to Present at the H.C. Wainwright Virtual 22nd Annual Global Investment Conference
|
|
|
Aug 13, 2020
|
Dynavax Announces Grant to Scale up CpG 1018 Adjuvant Capacity to Support the Global COVID-19 Response
|
|
|
Aug 06, 2020
|
Dynavax Announces Second Quarter 2020 Financial Results
|
|
|
Aug 03, 2020
|
TriSalus Life Sciences Acquires Dynavax’s SD-101 Oncology Program in Purchase Agreement for up to $250 million in Milestone Payments plus Royalties on Future Net Sales
|
|
|
Jul 30, 2020
|
Dynavax to Report Second Quarter 2020 Financial Results and Host Conference Call on August 6, 2020
|
|
